TrialActa oncologica (Stockholm, Sweden)2026

Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.

Kathinka Schmidt Slørdahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.